Sangamo Therapeutics Ownership | Who Owns Sangamo Therapeutics?
Sangamo Therapeutics Ownership Summary
Sangamo Therapeutics is owned by 25.83% institutional investors, 1.77% insiders, and 72.41% retail investors. Armistice capital is the largest institutional shareholder, holding 11.96% of SGMO shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 2.51% of its assets in Sangamo Therapeutics shares.
SGMO Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Sangamo Therapeutics | 25.83% | 1.77% | 72.41% |
| Sector | Healthcare Stocks | 35.74% | 11.83% | 52.43% |
| Industry | Biotech Stocks | 36.05% | 11.82% | 52.13% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Armistice capital | 40.40M | 11.96% | $9.97M |
| Vanguard group | 12.00M | 3.94% | $5.04M |
| Blackrock | 4.70M | 2.61% | $1.69M |
| Two sigma investments, lp | 6.27M | 1.86% | $1.55M |
| Balyasny asset management | 5.29M | 1.57% | $1.31M |
| Geode capital management | 4.57M | 1.35% | $1.13M |
| Blackrock funding, inc. /de | 4.55M | 1.35% | $1.12M |
| Renaissance | 3.84M | 1.14% | $947.27K |
| Two sigma advisers, lp | 2.11M | 0.82% | $1.42M |
| Ubs group | 2.57M | 0.76% | $635.03K |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Luminus management | 1.68M | 0.25% | $415.06K |
| Armistice capital | 40.40M | 0.18% | $9.97M |
| Hedges asset management | 125.00K | 0.04% | $52.50K |
| Sanders morris harris | 668.00K | 0.03% | $164.93K |
| Wealth management associates | 295.80K | 0.03% | $73.03K |
| Ikarian capital | 1.22M | 0.02% | $300.89K |
| Diametric capital, lp | 353.48K | 0.02% | $87.27K |
| Mak capital one | 561.54K | 0.02% | $138.64K |
| R squared | 89.87K | 0.01% | $22.19K |
| Meritage portfolio management | 227.00K | 0.01% | $95.34K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Armistice capital | 40.40M | 0.18% | 40.40M |
| Balyasny asset management | 5.29M | 0.00% | 5.29M |
| Vanguard fiduciary trust | 2.31M | 0.00% | 2.31M |
| Ubs group | 2.57M | 0.00% | 1.55M |
| Two sigma investments, lp | 6.27M | 0.00% | 1.51M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Blackrock | 4.70M | - | -8.57M |
| Renaissance | 3.84M | 0.00% | -4.59M |
| Acadian asset management | - | - | -4.56M |
| Jane street group | - | - | -2.92M |
| Point72 asset management | - | - | -2.00M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Armistice capital | 40.40M | 0.18% | 40.40M | $9.97M |
| Balyasny asset management | 5.29M | 0.00% | 5.29M | $1.31M |
| Vanguard fiduciary trust | 2.31M | 0.00% | 2.31M | $570.64K |
| Mak capital one | 561.54K | 0.02% | 561.54K | $138.64K |
| Marshall wace, llp | 303.86K | 0.00% | 303.86K | $75.97K |
Sold Out
| Holder | Change |
|---|---|
| Barclays | -1.00 |
| Headlands | -5.00 |
| Srs capital advisors | -31.00 |
| Td waterhouse canada | -31.00 |
| Gps wealth strategies group | -100.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2026 | 102 | -8.11% | 87,227,224 | 40.09% | 25 | 6.17% | 51 | 18.60% | 14 | -58.82% |
| Dec 31, 2025 | 37 | -68.91% | 15,567,844 | -75.13% | 5 | 0.86% | 15 | -72.73% | 8 | -60.00% |
| Sep 30, 2025 | 43 | -61.95% | 19,880,715 | -60.46% | 7 | 2.02% | 17 | -63.83% | 7 | -75.86% |
| Jun 30, 2025 | 118 | -9.92% | 51,227,326 | -2.55% | 19 | 3.50% | 47 | -16.07% | 32 | -5.88% |
| Mar 31, 2025 | 130 | -4.41% | 52,338,132 | -14.91% | 23 | 2.73% | 55 | -22.54% | 34 | 9.68% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard US Total Market Shares ETF | 5.65M | 2.51% | 1.00 |
| Wasatch Ultra Growth | 5.59M | 2.28% | 1.06M |
| Vanguard Total Stock Mkt Idx Inv | 7.96M | 1.92% | - |
| SPDR® S&P Biotech ETF | 3.73M | 1.75% | -22.75K |
| Wasatch Micro Cap | 2.34M | 1.12% | -3.31M |
| Vanguard Institutional Extnd Mkt Idx Tr | 4.46M | 1.08% | - |
| Vanguard Strategic Small-Cap Equity Inv | 1.71M | 0.82% | - |
| Vanguard Explorer Inv | 1.40M | 0.67% | - |
| Fidelity Extended Market Index | 2.10M | 0.51% | 321.57K |
| Schwab US Small-Cap ETF™ | 1.80M | 0.43% | -131.00 |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Apr 22, 2026 | Davis Gregory D | Head of Research & Technology | Sell | $17.69K |
| Apr 21, 2026 | Dubois-Stringfellow Nathalie | SVP-CHIEF DEVELOPMENT OFFICER | Sell | $89.18K |
| Sep 26, 2023 | BIOGEN INC. | - | Sell | $3.00M |
| Aug 29, 2022 | BIOGEN INC. | - | Sell | $2.13M |
| Aug 29, 2022 | Biogen MA Inc. | Sell | $526.52K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q2 | - | 2 |
| 2026 Q1 | - | - |
| 2025 Q4 | - | - |
| 2025 Q3 | - | - |
| 2025 Q2 | - | - |
SGMO Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools